Rheumatology Advisor

offers healthcare professionals a robust knowledge base of practical rheumatology information to assist in clinical decision making.

[Rheumatology Advisor @RheumAdvisor]

Optimal treatment for patients with co-occurring #PTSD and #fibromyalgia requires coordinated, multidisciplinary care.
https://t.co/CMQaPNQuHG

[Rheumatology Advisor @RheumAdvisor]

From @bmj_rmdopen: Patients with vs without #AnkylosingSpondylitis were associated with higher risks for renal complications, including #AcuteKidneyInjury and #ChronicKidneyDisease.
https://t.co/B4tXATVEgn

[Rheumatology Advisor @RheumAdvisor]

Engaging in a "weekend warrior" #PhysicalActivity pattern was associated with reduced #cardiovascular and mortality risks among individuals with #osteoarthritis.
https://t.co/T8xFCDkAoS

[Rheumatology Advisor @RheumAdvisor]

Men with #RheumatoidArthritis have higher odds of developing #HeartFailure compared with women, with differences driven largely by #IschemicDisease.
@ChariteBerlin #RheumX
https://t.co/FGNgjZ3UM6

[Rheumatology Advisor @RheumAdvisor]

Adults with higher Fracture Risk after Ischemic Stroke (FRAC-Stroke) scores are associated with an increased risk for minimal trauma #fracture following #IschemicStroke.

@ASBMR #RheumX
https://t.co/0gpGSayeom

[Rheumatology Advisor @RheumAdvisor]

Higher #RheumatoidArthritis disease activity was significantly associated with greater #frailty scores at both baseline and over time among US #veterans.
https://t.co/wuJGBaZffh

[Rheumatology Advisor @RheumAdvisor]

Significant differences in #OralMicrobiota were found between patients with primary #SjögrenSyndrome vs control individuals, with the former showing reduced diversity.
https://t.co/JHm7duxhHW

[Rheumatology Advisor @RheumAdvisor]

From #EULAR2026 and @eular_org: Treatment with subcutaneous #efgartigimod PH20 led to maintained or improved efficacy outcomes through 52 weeks and a consistent safety profile among adults with active idiopathic #InflammatoryMyopathy.
https://t.co/2eZbdsSnMe

[Rheumatology Advisor @RheumAdvisor]

From #EULAR2026 and @eular_org: #Semaglutide and #tirzepatide are effective for achieving #WeightLoss among patients with #rheumatic and #musculoskeletal diseases with and without #diabetes, with treatment patterns showing rising uptake.
https://t.co/KP87269efN

[Rheumatology Advisor @RheumAdvisor]

From #EULAR2026 and @eular_org: #Izokibep demonstrates durable efficacy and a favorable safety profile through 52 weeks among patients with active #PsoriaticArthritis, with sustained improvements across joint, skin, and quality of life outcomes.
https://t.co/d99rCnbVVw

[Rheumatology Advisor @RheumAdvisor]

From #EULAR2026 and @eular_org: #GLP1RA use is not associated with a significantly reduced risk for total #KneeReplacement compared with #metformin among older adults with #Type2Diabetes and #obesity.
https://t.co/8UApZpIXf0

[Rheumatology Advisor @RheumAdvisor]

From #EULAR2026 and @eular_org: Compared with placebo, #litifilimab treatment resulted in higher rates of clear or almost clear skin at weeks 16 and 24 among patients with #CutaneousLupusErythematosus.
https://t.co/susJx978tQ

[Rheumatology Advisor @RheumAdvisor]

While the role of the gut-joint axis has been recognized in #spondyloarthritis, evidence shows #diet should be used as an adjunct to medication. We spoke to @TheAthletesRD and Misha Balmuri, MD, of @HopkinsMedicine for their insight.
https://t.co/OGo9vwBozt

[Rheumatology Advisor @RheumAdvisor]

Patients with antineutrophil cytoplasmic antibody-associated #vasculitis have an increased risk for severe #infection relative to members of the general population, with recurrent infection risk patterns shifting over time.
https://t.co/YSMYgOgiHM

[Rheumatology Advisor @RheumAdvisor]

Among hospitalized patients with #SystemicLupusErythematosus, #electrocardiographic abnormalities were associated with an increased risk for major adverse #cardiovascular and #cerebrovascular events.
https://t.co/vhPwJsMRLe

[Rheumatology Advisor @RheumAdvisor]

#Malnutrition was associated with higher in-hospital mortality, greater odds of complications, and increased health care resource utilization among hospitalized patients with #dermatomyositis or #polymyositis. #RheumX
https://t.co/9FZi71EtLB

[Rheumatology Advisor @RheumAdvisor]

From @RheumJnl: #CalcinosisCutis is common among patients with #SystemicSclerosis and is associated with distinct clinical features, as well as an increased likelihood of progression over time. #RheumX
https://t.co/KIHJhjcrN3

[Rheumatology Advisor @RheumAdvisor]

From @JRheumatology: Excess weight negatively affects weight-specific quality of life among adolescents aged 11 through 19 years with #RheumaticDiseases, with #BodyEsteem emerging as the most impacted domain.
https://t.co/XFf93Mpfv9

[Rheumatology Advisor @RheumAdvisor]

#Metformin use was associated with a 23% lower risk for all-cause mortality among US adults with #arthritis.
https://t.co/FmmcYoz3kl

[Rheumatology Advisor @RheumAdvisor]

From @RheumJnl: Across #BiologicTherapies for #AntiphospholipidSyndrome, rituximab and eculizumab had the most robust data, while belimumab and daratumumab were promising but supported by very limited early evidence.
https://t.co/FRPg5gXDLl